Fatty liver index as an indicator of metabolic syndrome

被引:26
|
作者
Rogulj, Dinko [2 ]
Konjevoda, Pasko [3 ]
Milic, Mirta [4 ]
Mladinic, Marin [4 ]
Domijan, Ana-Marija [1 ]
机构
[1] Univ Zagreb, Fac Pharm & Biochem, Zagreb 10000, Croatia
[2] Polyclin Sunce, Zagreb, Croatia
[3] Rudjer Boskovic Inst, NMR Ctr, Zagreb, Croatia
[4] Inst Med Res & Occupat Hlth, Mutagenesis Unit, Zagreb 41000, Croatia
关键词
Fatty liver index; Metabolic syndrome; Oxidative stress; REPTree and SimpleCART algorithms; ROC curve analysis; C-REACTIVE PROTEIN; COMET ASSAY; DNA-DAMAGE; GAMMA-GLUTAMYLTRANSFERASE; OXIDATIVE DAMAGE; NATIONAL-HEALTH; ASSOCIATION; MARKERS; OBESITY; REPAIR;
D O I
10.1016/j.clinbiochem.2011.10.014
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objective: The aim of this study was to find an early indicator of metabolic syndrome (MetS). Design and methods: We measured several anthropometric, biochemical, haematological, and oxidative damage parameters in 128 middle-aged Caucasian men divided into two groups: patients with MetS (n=69) and healthy controls (n=59), and used Weka REPTree and SimpleCART algorithms to identify the most reliable predictor of MetS. Results: Oxidative damage parameters did not differ between the groups, suggesting that oxidative damage is less prominent at the early stage of MetS. The algorithms singled out fatty liver index (FLI) as the best variable for discriminating between healthy and MetS subjects. This finding was confirmed by the receiver-operating characteristic (ROC) curve analysis, which set FLI 68.53 as the threshold value for MetS diagnosis. Conclusions: FLI is the most reliable tool for diagnosing MetS. The absence of oxidative damage does not rule out oxidative stress but may indicate that MetS is at an early stage. (C) 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:68 / 71
页数:4
相关论文
共 50 条
  • [41] Clinical significance of fatty liver associated with metabolic syndrome
    Kogiso, Tomomi
    Moriyoshi, Yuriko
    Nagahara, Hikaru
    HEPATOLOGY RESEARCH, 2007, 37 (09) : 711 - 721
  • [42] Small, dense LDL in metabolic syndrome and fatty liver
    Matsumoto, T.
    Sugino, I.
    Nakano, S.
    Iso, K.
    Kuboki, K.
    Ueshiba, H.
    Yoshino, G.
    DIABETOLOGIA, 2008, 51 : S297 - S297
  • [43] Nonalcoholic fatty liver disease: A precursor of the metabolic syndrome
    Lonardo, Amedeo
    Ballestri, Stefano
    Marchesini, Giulio
    Angulo, Paul
    Loria, Paola
    DIGESTIVE AND LIVER DISEASE, 2015, 47 (03) : 181 - 190
  • [44] Effect of different modalities of exercise on Fatty Liver Index in patients with metabolic syndrome: The RESOLVE randomized trial
    Couret, Alexis
    King, James A.
    Pereira, Bruno
    Courteix, Daniel
    Obert, Philippe
    Vinet, Agnes
    Walther, Guillaume
    Lesourd, Bruno
    Chapier, Robert
    Zak, Marek
    Bagheri, Reza
    Ugbolue, Chris U.
    Abergel, Armand
    Thivel, David
    Dutheil, Frederic
    Ennequin, Gael
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2024, 48 (08)
  • [45] Unveiling the Hepatic Harbinger: Assessing the Fatty Liver Index as a Predictor of Metabolic Syndrome in Female Healthcare Workers
    Yogesh, M.
    Vamja, Roshni
    Vala, Vijay
    Ramachandran, Arya
    Surati, Bhumika
    Nagda, Jay
    INDIAN JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2024, 28 (04) : 293 - 297
  • [46] Predictive Value of Lipid Accumulation Product, Fatty Liver Index, Visceral Adiposity Index for Metabolic Syndrome According to Menopausal Status
    Lee, Hyun Joo
    Jo, Hyun Nyung
    Kim, Yun Hwa
    Kim, Seung Chul
    Joo, Jong Kil
    Lee, Kyu Sup
    METABOLIC SYNDROME AND RELATED DISORDERS, 2018, 16 (09) : 477 - 482
  • [47] Effects of garlic powder supplementation on metabolic syndrome components, insulin resistance, fatty liver index, and appetite in subjects with metabolic syndrome: A randomized clinical trial
    Sangouni, Abbas Ali
    Alizadeh, Mohammad
    Jamalzehi, Atena
    Parastouei, Karim
    PHYTOTHERAPY RESEARCH, 2021, 35 (08) : 4433 - 4441
  • [48] Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome
    Luca Miele
    Giovanni Gasbarrini
    Valentina Giorgio
    Antonio Gasbarrini
    Antonio Grieco
    Internal and Emergency Medicine, 2016, 11 : 3 - 10
  • [49] Nonalcoholic fatty liver disease as trigger of cardiovascular and metabolic complication in metabolic syndrome
    Miele, Luca
    Gasbarrini, Giovanni
    Giorgio, Valentina
    Gasbarrini, Antonio
    Grieco, Antonio
    INTERNAL AND EMERGENCY MEDICINE, 2016, 11 (01) : 3 - 10
  • [50] Association of Nonalcoholic Fatty Liver Disease With Components of Metabolic Syndrome According to Body Mass Index in Korean Adults
    Kwon, Young-Min
    Oh, Seung-Won
    Hwang, Seung-sik
    Lee, CheolMin
    Kwon, Hyuktae
    Chung, Goh Eun
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2012, 107 (12): : 1852 - 1858